In a study on liver cancer using Hep3B and HepG2 cells with the tet-on system and verified by soft agar colony assays and xenograft models, Li et al. observed that CAR represses hepatocarcinogenesis by inhibiting erythropoietin signalling18. The gene discussed is NR1I3; the disease is liver cancer.